We also found that the MIF cytokine, miR26a, a panel of miRNAs associated with inflammatory regulation, and liquid biopsies detecting early mutations could be potential biomarkers of CRC diagnosis and prognosis. This evidence concerns the gene MIF and colorectal carcinoma.